echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The cumulative output value of two vaccine companies in Beijing exceeded 120 billion yuan, driving the industry to maintain rapid growth in the first half of the year

    The cumulative output value of two vaccine companies in Beijing exceeded 120 billion yuan, driving the industry to maintain rapid growth in the first half of the year

    • Last Update: 2021-08-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network, July 21.
    In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
    The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
    .
     
    The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
    .
    In the first half of 2021, Beijing's economic performance was stable and improving.
    In the first half of 2021, GDP grew by 13.
    4% year-on-year, 0.
    7 percentage points higher than the national level
    .
     
      In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
    4% year-on-year, and the two-year average growth rate was 16.
    7%, which was 25.
    5 and 9.
    7% higher than the national level respectively
    .
    Among them, the lead of the vaccine industry is very eye-catching
    .
     
      As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
    61%
    .
    Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
    The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
     
      In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
    .
     
      In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
    7% year-on-year, and the two-year average growth was 20.
    3%; the high-tech manufacturing and strategic emerging industries increased by 54.
    4% and 42.
    8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
    2% and 5% year-on-year respectively.
    In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
    .
    (Finish)
      Medical Network, July 21.
    In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
    The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
    .
     
      The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
    .
    In the first half of 2021, Beijing's economic performance was stable and improving.
    In the first half of 2021, GDP grew by 13.
    4% year-on-year, 0.
    7 percentage points higher than the national level
    .
     
      In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
    4% year-on-year, and the two-year average growth rate was 16.
    7%, which was 25.
    5 and 9.
    7% higher than the national level respectively
    .
    Among them, the lead of the vaccine industry is very eye-catching
    .
     
      As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
    61%
    .
    Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
    The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
     
      In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
    .
     
      In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
    7% year-on-year, and the two-year average growth was 20.
    3%; the high-tech manufacturing and strategic emerging industries increased by 54.
    4% and 42.
    8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
    2% and 5% year-on-year respectively.
    In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
    .
    (Finish)
      Medical Network, July 21.
    In the first half of this year, the production of four new crown vaccines led by Beijing accounted for about 90% of the country; two were produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    The cumulative output value of vaccines exceeded 120 billion yuan (RMB, the same below), driving the added value of the pharmaceutical manufacturing industry to increase by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
    The vaccine industry has not only contributed Beijing's strength to the fight against the epidemic, but has also become a nuclear explosion that supports the rapid growth of the industry
    .
     
      The above was introduced by the relevant person in charge of the Beijing Municipal Development and Reform Commission at the media interpretation meeting held on the 20th
    .
    In the first half of 2021, Beijing's economic performance was stable and improving.
    In the first half of 2021, GDP grew by 13.
    4% year-on-year, 0.
    7 percentage points higher than the national level
    .
     
      In the first half of this year, the value added of the industrial enterprises above designated size in Beijing increased by 41.
    4% year-on-year, and the two-year average growth rate was 16.
    7%, which was 25.
    5 and 9.
    7% higher than the national level respectively
    .
    Among them, the lead of the vaccine industry is very eye-catching
    .
     
      As of 12:00 on July 20, the coverage rate of the new crown vaccine for people aged 18 and over in Beijing reached 90.
    61%
    .
    Four vaccines have been approved for conditional listing or emergency use in China, and the output accounts for about 90% of the country.
    The cumulative output value of the two vaccines produced by Sinopharm Beijing Institute of Biological Products and Beijing Kexing Zhongwei Biotechnology Co.
    , Ltd.
    exceeded 120 billion The value added of the pharmaceutical manufacturing industry increased by 2.
    9 times, an average growth rate of 94.
    2% in two years
    .
    Medicine Medicine Medicine
     
      In the first half of this year, Beijing saw new results in the construction of high-precision economic structure, new adjustments in the demand structure, and a new look in the distribution of productivity
    .
     
      In addition to the vaccine industry, in the first half of the year, the added value of Beijing's electronics industry increased by 25.
    7% year-on-year, and the two-year average growth was 20.
    3%; the high-tech manufacturing and strategic emerging industries increased by 54.
    4% and 42.
    8% respectively in the two-year average, leading high-end companies This feature is more prominent; the added value of the information service industry and the financial industry increased by 17.
    2% and 5% year-on-year respectively.
    In the first half of the year , there were 37 new listed companies , of which 9 were listed on the Science and Technology Innovation Board, and the industry's supporting role was more obvious
    .
    (Finish)
    Enterprise business enterprise
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.